25.6 C
Vientiane
Monday, September 15, 2025
spot_img
Home Blog Page 14

SUS ENVIRONMENT Takes Center Stage at WMAM 2025 with Cutting-Edge WtE and AI-Twin Digital in Malaysia

SHANGHAI, Sept. 12, 2025 /PRNewswire/ — SUS ENVIRONMENT, a leading global environmental technology innovator, made a powerful impact at the Waste Management Association of Malaysia (WMAM) 20th Anniversary Annual Conference, held on at Royale Chulan Kuala Lumpur.

The event, themed “Smart Waste Management: Harnessing Technology for a Greener Tomorrow”, is one of the largest and most important platforms in Malaysia, bringing together government leaders, regulators, industry players, and waste management “warriors” from across the country and region. Distinguished guests attending the conference included:

  • YB Nga Kor Ming, Minister of Housing and Local Government (KPKT) 
  • Dato’ Azhar bin Yahya, Director General, Department of National Solid Waste Management (JPSPN)
  • YB Tuan Hee Loy Sian, Chairman of Solid Waste Management and Public Cleansing Corporation (SWCorp)
  • YB Khalid bin Mohamed, Chief Executive Officer of SWCorp

In addition, Mr. James Law, President of the International Solid Waste Association (ISWA), Mr. Xu Moqiang, Vice President of the China Association of Urban Environmental Sanitation (CAUES), and other representatives from international solid waste organizations attended the conference.

At the conference forum, Mr. Eric Zhan, CEO of SUS International, delivered a spotlight presentation. He outlined global development trends in waste-to-energy, emphasizing that China has made the greatest progress in the past decade, while Southeast Asia has now become the fastest-growing region. He also shared China’s best practices tailored to Malaysia’s waste profile, covering areas such as high-efficiency power generation, bottom ash utilization, zero-landfill fly ash treatment, AI and digital twin applications, and carbon emission monitoring.

At the SUS ENVIRONMENT exhibition booth, a 3D model of a waste-to-energy project and the company’s latest AI-Twin Digital technology were showcased. The WtE 3D model, combined with a complete incineration process display, allowed participants to gain a direct and intuitive understanding of the entire waste-to-energy process. Meanwhile, the AI-Twin Digital system recreated the real-time operational performance of the Xi’an SUS WtE project in the form of a full 3D digital model, brought vividly to life at the venue in Kuala Lumpur, Malaysia.

The Malaysian Minister of Housing, YB Nga Kor Ming, together with WMAM Chairman Mr. Ho De Leong, presented a gift to SUS ENVIRONMENT at the venue. On behalf of the company, Dr. Long Jisheng, Chairman of SUS ENVIRONMENT, reciprocated with China’s Best Available Techniques (CBAT), for which he served as chief editor.

The Gala Dinner graced by the presence of mayors, city council representatives from across Malaysia, as well as senior leaders from JPSPN and SWCorp. During the evening, SUS’s leadership was further recognized with an Award of Excellence for Waste Management Initiatives, honouring the company’s outstanding contributions to advancing sustainable solutions in Malaysia. The award was presented by Mr. James Law, President of ISWA together with Mr. Ho De Leong, President of WMAM.

Through continuous innovation and localized practices, SUS is committed to working with partners across sectors to drive green transformation and sustainable development, contributing to a cleaner and smarter Malaysia.

 

Gemini Announces Pricing of Initial Public Offering

NEW YORK, Sept. 12, 2025 /PRNewswire/ — Gemini Space Station, Inc. (“Gemini”), a global crypto platform, today announced the pricing of its initial public offering of 15,178,572 shares of Class A common stock at a public offering price of $28.00 per share. In connection with the offering, Gemini and the selling stockholders intend to grant the underwriters a 30-day option to purchase up to an additional 300,565 and 458,364 shares of Class A common stock, respectively, to cover over-allotments. Gemini will not receive any proceeds from any sale of shares by the selling stockholders. Gemini’s Class A common stock is expected to begin trading on the Nasdaq Global Select Market on September 12, 2025 under the ticker symbol “GEMI” and the offering is expected to close on September 15, 2025, subject to customary closing conditions.

Goldman Sachs & Co. LLC and Citigroup are acting as lead bookrunners. Morgan Stanley and Cantor are also acting as lead bookrunners. Evercore ISI, Mizuho, Truist Securities, Cohen & Company Capital Markets, Keefe, Bruyette & Woods, A Stifel Company, Needham & Company, and Rosenblatt are acting as bookrunners. Academy Securities, AmeriVet Securities, and Roberts & Ryan are acting as co-managers.

The offering is being made only by means of a prospectus. Copies of the prospectus relating to this offering may be obtained by visiting EDGAR on the Securities and Exchange Commission’s (the “SEC”) website at www.sec.gov. Alternatively, copies of the prospectus may be obtained from Goldman Sachs & Co. LLC, Attention: Prospectus Department, 200 West Street, New York, New York 10282, telephone: 1-866-471-2526, or email: prospectus-ny@ny.email.gs.com; or Citigroup, c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY 11717 (Tel: 800-831-9146).

A registration statement relating to these securities has been filed with, and declared effective by, the SEC. This press release shall not constitute an offer to sell or the solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

About Gemini

Gemini is a global crypto platform founded by Cameron and Tyler Winklevoss in 2014. Gemini offers a wide range of crypto products and services for individuals and institutions in over 60 countries. Gemini’s simple, reliable, and secure products are built to unlock the next era of financial, creative, and personal freedom.

Contacts

Investors
Gemini Investor Relations
Email: investors@gemini.com

Press
Natalie Rix
Email: press@gemini.com

Smartee and Shanghai Ninth People’s Hospital Win First Prize at Shanghai Science and Technology Progress Awards

SHANGHAI, Sept. 12, 2025 /PRNewswire/ — Smartee Denti-Technology, a global innovator in invisible orthodontic solutions, together with Shanghai Ninth People’s Hospital affiliated with Shanghai Jiao Tong University School of Medicine, has been awarded the First Prize of the Shanghai Science and Technology Progress Award. This prestigious recognition highlights the two institutions’ joint achievements in advancing precision surgery for complex craniofacial deformities.

Award and Background:

The Shanghai Science and Technology Progress Award, established by the Shanghai Municipal People’s Government, is among the city’s most prestigious honors. It recognizes major scientific and technological achievements that drive original innovation in scientific discoveries and technological inventions, promote industrial transformation and strategic industry development, and advance urban safety, ecological health, and regional economic growth. Receiving the First Prize highlights the project’s significant contribution to both clinical medicine and digital healthcare innovation.

Project Overview:

The winning project, “Establishment and Application of a Key Technological System for Precision Surgery in Complex Craniofacial Deformities,” integrates the clinical expertise of Shanghai Ninth People’s Hospital’s Department of Oral and Craniomaxillofacial Surgery with Smartee’s leading capabilities in digital simulation and intelligent manufacturing. Together, the partners have developed a comprehensive technological system that improves diagnosis, planning, and treatment outcomes for patients with severe craniofacial anomalies.

Clinical Value:

Complex craniofacial deformities, often involving severe jaw developmental anomalies and malocclusion, require multi-disciplinary care and pose long-standing challenges for clinicians. This project establishes an integrated model that enhances surgical precision, reduces treatment risks, and enables personalized, patient-specific solutions.

Smartee’s Contribution and Impact:

As a pioneer in clear aligners and digital orthodontic technology, Smartee contributed its expertise by developing a comprehensive suite of tools for complex craniofacial cases. These include surgical planning systems, orthodontic-orthognathic case management software, integrated simulation and demonstration platforms, as well as intraoperative and postoperative clear guides. Together, these innovations form a full-process digital solution that supports joint orthodontic-orthognathic treatments, enhancing precision and efficiency in clinical practice.

Future Outlook:

Looking ahead, Smartee will continue to expand the application of these technologies to broader clinical settings, promoting international academic exchange and providing patients worldwide with access to safer and more effective orthodontic treatments.

To learn more about Smartee’s innovations in orthodontics, visit: www.smarteealigners.com

 

“My Yunnan Flavor” Topic Challenge to Be Launched

KUNMING, China, Sept. 12, 2025 /PRNewswire/ — The “My Yunnan Flavor” topic challenge will be launched by Yunnan SYNDA Information Industry Co., Ltd. From August 20, 2025 to September 30, 2025, creators around the world are invited to capture Yunnan’s distinctive tastes and bustling market life in short, shareable videos. Anchored by the five-flavor theme — Sour, Sweet, Bitter, Spicy, Umami — the campaign highlights local dishes, spring market rituals and everyday street culture, while celebrating five corresponding cultural ethos that make Yunnan uniquely vibrant.

Beyond the official themed video series, the event features a playful “100 Yuan Market Challenge,” where creators explore local markets with just 100 RMB to discover iconic snacks. A series of short interviews with foreign visitors will offer fresh, cross-cultural perspectives, and select collaborations with international KOLs will help bring Yunnan’s flavors to a global audience. Top submissions will be promoted across our channels and tied into offline market events to maximize engagement and impact.

How to join: Post your original video with the hashtag #MyYunnanFlavor, tag @visityunnan, or email entries to lilyzhangll727@gmail.com; Follow our official account for full rules and the latest updates — we can’t wait to see Yunnan through your lens!

Official Links:

YouTube: https://www.youtube.com/@visityunnan21

TikTok: https://www.tiktok.com/@visityunnan

Major Content Update ‘Unconditional Love Phase 1’ Arrives in Persona5: The Phantom X


TAIPEI, TAIWAN – Media OutReach Newswire – 12 September 2025 – Persona 5: The Phantom X has officially released Version 2.0, titled “Unconditional Love Phase 1.” This significant update introduces a wealth of new content, including a brand-new main story chapter, a new playable Phantom Thief, a new palace, a new area to explore, and a variety of in-game events and bundles.

Unconditional Love Phase 1

The Version 2.0 update introduces the newest 5 Star Phantom Thief, Ayaka Sakai, voiced by Yui Makino. Ayaka Sakai is a shy college student and musician who plays rhythm guitar. Despite her band’s breakup, her passion for music remains, leading her on a new journey.

PublisherTMPCwwuy7.jpg

Players can now dive into Chapter 3 of the main story, where they will team up with Riko to solve new problems and challenges. This chapter also unlocks a new palace, Dam, and the new explorable area of Kichijoji, where players can discover rewards and more.

To celebrate this major content release, the operations team has prepared a series of events and rewards for all players.

  • 7-Day Login Event: Log in for seven days during the event to earn a total of 20 Platinum Tickets and 20 Platinum Milicoins.
  • New Update Reward: Log in to claim 60 Thief’s Cognitite Shards, which can be redeemed for a specific Thief’s Cognitite.
  • Mission Completion Rewards: Complete objectives in the new Chapter 3 content to earn Meta Jewels, Joy Medals, and the exclusive event item, Mizuhiki Knots.

Additionally, fan-favourite Phantom Thieves, Ren Amamiya, is returning to idol contracts. During this limited-time event, players have an increased chance to obtain these highly sought-after characters. Don’t miss this opportunity to add them to your team!

Persona5: The Phantom X is now officially available for download on iOS, Android, and PC platforms in Southeast Asia.

– App Store: https://apps.apple.com/app/id6745494137
– Google Play Store: https://play.google.com/store/apps/details?id=sea.com.iwplay.p5x
– PC: https://p5x.pse.is/PCDL
Hashtag: #P5X #P5 #persona5x





The issuer is solely responsible for the content of this announcement.

Demand AI Group Secures $2.5 Million in Funding from International Institutional and Local Investors

DENVER, Sept. 12, 2025 /PRNewswire/ — Demand AI Group Inc. (“Demand AI”), the fast-growing AI-driven B2B marketing and lead-generation company, today announced the successful close of a $2.5 million investment round backed by a syndicate of international institutional investors and strategic local partners.

Demand AI Group
Demand AI Group

The funding marks a significant milestone in Demand AI’s rapid global expansion. Since its inception earlier this year, the company has established operations across nine countries, delivering a next-generation AI-powered alternative to traditional lead-generation models. With its proprietary technology and proven leadership team—who previously scaled and exited Selling Simplified Group to IDG/Blackstone in 2022—Demand AI is uniquely positioned to transform the way businesses generate demand and connect with customers.

“We are thrilled to welcome both international institutions and local investors who share our vision of reshaping the B2B demand-generation industry with AI,” said Michael Whife, CEO of Demand AI Group. “This funding provides us with the runway to accelerate growth, expand into new markets, and seize on acquisition opportunities as the industry continues to shift away from legacy models.”

The $2.5M raise will be used to:
-Accelerate global expansion with new offices across Europe and Asia-Pacific.
-Scale the sales and delivery teams to meet surging demand from enterprise clients.
-Invest in proprietary AI-driven systems to further differentiate Demand AI’s platform and services.
-Explore strategic acquisitions to consolidate market share in a rapidly evolving industry.

Demand AI is poised for unprecedented growth as businesses embrace conversational AI and intelligent automation, signaling a major shift in how the industry approaches demand generation.

Demand AI continues to attract top talent globally, with recent leadership hires in Europe, the Middle East, and Asia-Pacific, further strengthening its ability to deliver at scale.

About Demand AI Group Inc.
Demand AI Group is a global AI-driven demand-generation company headquartered in Denver, Colorado. Founded by Michael and Charlie Whife, industry veterans with a proven track record of scaling and exiting global businesses, Demand AI provides enterprises with AI-powered marketing, lead generation, and content solutions. The company currently operates in nine countries across Europe, Asia, and North America, delivering measurable results and industry-leading ROI.

 

The New Drug Application for KN026 (Anbenitamab Injection) Has Been Accepted by the National Medical Products Administration

SUZHOU, China, Sept. 12, 2025 /PRNewswire/ — Alphamab Oncology (Stock Code: 9966.HK) announced that the New Drug Application (NDA) for anbenitamab injection (KN026), independently developed by the Company and co-developed with JMT-Bio Technology Co., Ltd., a wholly-owned subsidiary of CSPC Pharmaceutical Group Co., Ltd. (stock code: 1093.HK), has been accepted by the National Medical Products Administration (NMPA). KN026 has been applied for as a Class 1 therapeutic biological product and the indication is for use in combination with chemotherapy for the treatment of patients with HER2-positive locally advanced, recurrent, or metastatic gastric or gastroesophageal junction cancer who have failed at least one prior systemic therapy (which must include trastuzumab in combination with chemotherapy).

This NDA for KN026 is primarily based on a pivotal Phase II/III clinical trial (Study ID: KN026-001). Results from the first interim analysis of the Phase III clinical study demonstrated that, compared to the current standard of care, KN026 combined with chemotherapy significantly improved clinical efficacy, by prolonging progression-free survival (PFS) and overall survival (OS). Furthermore, the combination showed no new safety signals, with a low incidence of cardiotoxicity and low immunogenicity in terms of safety profile. Previously, results from the Phase II clinical study, presented at the 2024 European Society for Medical Oncology (ESMO) Congress, showed that KN026 in combination with chemotherapy achieved an objective response rate (ORR) of 40.0%, with a median PFS of 8.6 months as assessed by the independent review committee (IRC). KN026 was granted Breakthrough Therapy Designation by the Center for Drug Evaluation (CDE) of the NMPA on November 4, 2023, and received Priority Review status on August 28, 2025.

Currently, there are no approved anti-HER2 therapies for the second-line treatment of HER2-positive gastric cancer. KN026 is the first HER2 bispecific antibody to demonstrate positive results in the second-line treatment of gastric cancer in China. Meanwhile, multiple pivotal Phase III clinical studies of KN026 in gastric cancer and breast cancer are undergoing smoothly, with the aim of benefiting more patients.

About KN026

KN026 is an anti-HER2 bispecific antibody independently developed by Alphamab Oncology using the proprietary Fc-based heterodimer bispecific platform technology called CRIB (Charge Repulsion Induced Bispecific). KN026 can simultaneously bind two non-overlapping epitopes of HER2, leading to HER2 signal blockade. KN026 has demonstrated better tumor inhibition in HER2-positive tumor cell lines compared with trastuzumab and pertuzumab in combination. Additionally, KN026 has also shown inhibitory effect on tumor cells with trastuzumab-resistant cell lines.

The results of multiple clinical studies in different stages showed that KN026 has significant anti-tumor activities, even in heavily pretreated patients with HER2-positive breast cancer (BC) and gastric cancer (GC), including those with prior anti-HER2 treatment. Currently, several pivotal clinical trials of KN026 for the second-line or above treatment of HER2-positive GC/gastroesophageal junction cancer (GEJ), the first-line treatment of HER2-positive BC, neoadjuvant treatment for HER2-positive BC are being conducted. KN026 in combination with chemotherapy for the treatment of patients with HER2-positive GC (including GEJ) who have failed first-line standard treatment was granted breakthrough therapy designation by the Center for Drug Evaluation (CDE) of the National Medical Products Administration of China (NMPA).

In August 2021, the Company entered an agreement with JMT-Bio Technology Co., Ltd. (“JMT-Bio”), a wholly-owned subsidiary of CSPC Pharmaceutical Group Co., Ltd. (“CSPC”) (stock code: 1093.HK), for the development and commercialization of KN026 in Mainland China, pursuant to which, JMT-Bio was granted exclusive license rights of KN026 for the development and commercialization in the indications of BC an GC/GEJ in Mainland China (excluding Hong Kong, Macau and Taiwan).

About Alphamab Oncology

Alphamab Oncology is an innovative biopharmaceutical company focusing on oncology therapeutics. On December 12, 2019, the Company was successfully listed on the Main Board of the Hong Kong Stock Exchange, trading under the stock code 9966.

By leveraging its proprietary core technology platforms including single-domain antibodies, bispecific antibodies, glycan-specific conjugation, linker-payload, dual-payload antibody conjugation, and subcutaneous high concentration formulation for biologics, the Company has established a product portfolio with differentiated innovation and global competitiveness, covering cutting-edge areas such as antibody-drug conjugates (ADCs), bispecific antibodies, and single-domain antibodies.

The Company has one product approved for marketing (Envafolimab, the world’s first subcutaneously injectable PD-(L)1 inhibitor), which has made a significant breakthrough in the convenience and accessibility of cancer treatment. Additionally, the Company has multiple bispecific antibodies and bispecific ADCs in clinical stage, while rapidly advancing the preclinical pipeline prioritizing bispecific ADCs and dual-payload ADCs. Multiple strategic collaborations based on innovative products or technology platforms have been established with partners such as CSPC, ArriVent, and Glenmark.

Our overarching mission is to make cancer manageable and curable by addressing unmet clinical needs in oncology. Alphamab Oncology is continuously dedicated to the development of effective, safe, and globally competitive anti-tumor drugs, delivering China-innovated cancer therapies to benefit patients worldwide.

 

Submarine Networks World 2025 – the annual flagship event for the global subsea industry returns to Singapore in September.

SINGAPORE, Sept. 11, 2025 /PRNewswire/ — Submarine Networks World, the No.1 annual event for subsea communications professionals returns to Singapore on September 24th  and 25th.

Submarine Networks World 2025 returns to Singapore on September 24th  and 25th
Submarine Networks World 2025 returns to Singapore on September 24th  and 25th

FOR IMMEDIATE RELEASE. Being held for the first time at Sands Expo & Convention Centre, Submarine Networks World 2025 (organised by Terrapinn) will welcome over 1,000 attendees and participants from across the global subsea industry.

Everyone from cable owners/operators, consortium members, technology providers, innovators, consultants, service partners, government entities, financiers, surveying companies – the whole industry – will be onsite at the true ‘one-stop shop’ for any subsea cable project.

Subsea infrastructure underpins how the world lives and works, making this gathering critical for the industry’s future. For 2025, we’ve brought together an outstanding line-up of leaders to share their insights, while the exhibition floor will showcase solutions designed to drive progress. We’re thrilled to welcome the global subsea community back to Singapore for what will be the largest edition yet,” said Paul Clark, Managing Director (Asia), Terrapinn.

This year’s event features more than 70 sponsors, exhibitors, and partners, including Title Sponsor Nokia, Platinum Sponsor Ciena, and Gold Sponsors ASN, Digital Realty, HMN Tech, Mobily, center3, Huawei and Telecom Egypt.

Attendees will hear from 130 influential speakers from every inhabited continent around the world. Both mornings begin with the daily Keynote sessions and then following are six specialist theatres, with three running each day. Choose from: Defence, Cable, Data Centres & CLS, Strategy, Network and O&M.

Keynote Speakers Include:

  • Abdullah A. Alghonaimi, VP Wholesale Operations, Mobily
  • Rayan Alsaedi, Senior Advisor, Digital Infrastructure and Communication Deputyship, MCIT (Kingdom of Saudi Arabia)
  • Mohamed Eldahshory, Director, Global Projects & Submarine Cable Development, Telecom Egypt
  • Farhan Mohamed Bouh, Managing Director – Senior Executive Advisor, DjiboutiTelecom
  • Hasnain Ali, Director Permitting & Regulatory Affairs, Pioneer Consulting
  • Dr. Stephen J McCombie, Professor of Maritime IT Security, NHL Stenden University of Applied Sciences
  • Shimada Shinya, Deputy Director-General for Global Strategy, MIC Japan
  • Jurgen Hatheier, Vice President International CTO, Ciena
  • Mark Brownscombe, Senior Director – Commercial & Sales Ops, Ooredoo
  • Anup Gupta, President – India and SAARC, APTelecom
  • Ivan Skenderoski, Managing Partner, Salience Consulting
  • Alpheus Mangale, Group CEO, SEACOM
  • Carine Romanita, Head of Networks Strategy and SubMarine Systems, Orange
  • Carlos Casado, VP of Sales, Telxius, Northern Region
  • Craig Davis, Senior Manager, Electronic Communications, Regulatory Authority Bermuda
  • Erick W.Contag, President of the Board of Trustees, SubOptic Foundation
  • Julian Rawle, Associate, Cambridge MC
  • Nadya Melic, VP – Product & Marketing, FLAG
  • Russ Matulich, CEO, RTI Advisors
  • Prenesh Padayachee, Group Chief Digital and Operations Officer, SEACOM
  • Ubaid Younus, Network Investment Manager – APAC, Meta
  • Isabelle Paradis, President, HOT Telecom
  • Alan Mauldin, Research Director, TeleGeography

For event information and the full conference agenda, visit: https://www.terrapinn.com/SNW2025PRNEWS 

PR Newswire is the official news distribution partner of Submarine Networks World 2025.

About Submarine Networks World 2025: 
Submarine Networks World 2025 will take place on 24 – 25 September 2025 at Suntec Convention & Exhibition Centre in Singapore. Firmly established as the world’s largest annual gathering of the global subsea communications community, Submarine Networks World is the dedicated platform to exchange knowledge, explore the latest projects, develop strategies and form lucrative new partnerships to drive the industry forward.  

About Terrapinn: 
Terrapinn has been sparking ideas, innovations and relationships that transform business for over 30 years. Using our global footprint, we bring innovators, disrupters and change agents together, discussing and demonstrating the technology, strategies and personalities that are changing the way the world does business. Whether you’re looking to make new connections, introduce a product or inspire change in your industry, we invite you to join us as agitators of change. Terrapinn – spark something. 

Press attendance is complimentary. Enquiries should be directed to:
Amira Azli
Marketing Executive
Terrapinn Asia
amira.azli@terrapinn.com